Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronavirus Infections | 2 | 2020 | 71 | 0.320 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 104 | 0.310 |
Why?
|
Developing Countries | 2 | 2021 | 400 | 0.300 |
Why?
|
Medical Oncology | 1 | 2025 | 1 | 0.250 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2025 | 21 | 0.240 |
Why?
|
Palliative Care | 1 | 2025 | 52 | 0.240 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 293 | 0.220 |
Why?
|
Neoplasms | 1 | 2025 | 147 | 0.210 |
Why?
|
Acetaminophen | 1 | 2022 | 1 | 0.210 |
Why?
|
Hypothermia, Induced | 1 | 2021 | 17 | 0.190 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2021 | 21 | 0.190 |
Why?
|
Pandemics | 2 | 2020 | 296 | 0.180 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 73 | 0.180 |
Why?
|
Hodgkin Disease | 1 | 2020 | 11 | 0.180 |
Why?
|
Mothers | 1 | 2022 | 195 | 0.180 |
Why?
|
Equipment Design | 1 | 2020 | 27 | 0.180 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 11 | 0.180 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 34 | 0.170 |
Why?
|
Occupational Exposure | 1 | 2020 | 35 | 0.170 |
Why?
|
Sentinel Surveillance | 1 | 2020 | 115 | 0.170 |
Why?
|
Blood Specimen Collection | 2 | 2016 | 13 | 0.170 |
Why?
|
Humans | 11 | 2025 | 14537 | 0.160 |
Why?
|
Drug Monitoring | 1 | 2016 | 55 | 0.130 |
Why?
|
Critical Illness | 1 | 2016 | 44 | 0.130 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 529 | 0.120 |
Why?
|
Research Design | 1 | 2016 | 124 | 0.120 |
Why?
|
South Africa | 6 | 2025 | 7596 | 0.120 |
Why?
|
Infant, Newborn | 3 | 2025 | 1479 | 0.120 |
Why?
|
Child | 3 | 2025 | 2242 | 0.100 |
Why?
|
Betacoronavirus | 2 | 2020 | 52 | 0.090 |
Why?
|
Retrospective Studies | 2 | 2025 | 799 | 0.080 |
Why?
|
Exercise | 2 | 2022 | 205 | 0.080 |
Why?
|
Female | 4 | 2025 | 9103 | 0.080 |
Why?
|
Male | 3 | 2025 | 6754 | 0.080 |
Why?
|
Adolescent | 2 | 2025 | 2985 | 0.060 |
Why?
|
Cerebral Intraventricular Hemorrhage | 1 | 2025 | 2 | 0.060 |
Why?
|
Cerebral Hemorrhage | 1 | 2025 | 8 | 0.060 |
Why?
|
Infant, Premature, Diseases | 1 | 2025 | 19 | 0.060 |
Why?
|
Infant, Premature | 1 | 2025 | 56 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2025 | 253 | 0.060 |
Why?
|
Africa | 1 | 2025 | 376 | 0.050 |
Why?
|
Pain Measurement | 1 | 2022 | 15 | 0.050 |
Why?
|
Surveys and Questionnaires | 1 | 2025 | 563 | 0.050 |
Why?
|
Pain | 1 | 2022 | 41 | 0.050 |
Why?
|
HIV Infections | 1 | 2020 | 5097 | 0.050 |
Why?
|
Hospitals | 1 | 2022 | 103 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2022 | 81 | 0.050 |
Why?
|
Prevalence | 1 | 2025 | 1192 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2022 | 480 | 0.050 |
Why?
|
Air Pressure | 1 | 2020 | 1 | 0.040 |
Why?
|
Aerosols | 1 | 2020 | 7 | 0.040 |
Why?
|
Risk Factors | 1 | 2025 | 1475 | 0.040 |
Why?
|
Personal Protective Equipment | 1 | 2020 | 16 | 0.040 |
Why?
|
Vaccination | 1 | 2022 | 365 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 199 | 0.040 |
Why?
|
Research | 1 | 2020 | 65 | 0.040 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 56 | 0.040 |
Why?
|
Prenatal Care | 1 | 2020 | 147 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 1160 | 0.040 |
Why?
|
Mass Screening | 1 | 2020 | 245 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 1422 | 0.040 |
Why?
|
Uncertainty | 1 | 2016 | 7 | 0.030 |
Why?
|
Solid Phase Microextraction | 1 | 2016 | 2 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 156 | 0.030 |
Why?
|
Infant | 1 | 2022 | 2244 | 0.030 |
Why?
|
Dried Blood Spot Testing | 1 | 2016 | 24 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 125 | 0.030 |
Why?
|
Sepsis | 1 | 2016 | 102 | 0.030 |
Why?
|
Pregnancy | 1 | 2020 | 1862 | 0.030 |
Why?
|
Animals | 1 | 2016 | 1081 | 0.030 |
Why?
|
Adult | 1 | 2022 | 5913 | 0.020 |
Why?
|